Introduction
Adenosine is commonly accepted as a neuromodulator in central nervous system (CNS) with an inhibitory action on synaptic activity and neurotransmitter release. 1 Low extracellular levels of adenosine in brain activate adenosine A 1 and A 2a receptors under physiological conditions. 2 Both receptors are blocked by methylxanthines. 2 The methylxanthine caffeine is the most common CNS stimulant in everyday life. The proconvulsant action of adenosine antagonists such as caffeine, aminophylline and other methylxanthines was described both in adult 3 and in young rats. 4, 5 Moreover, it has been shown that immature rats are more susceptible to methylxanthines than the adult animals. 6 Nowadays, methylxanthines are among the most often prescribed drugs in neonatal medicine 7 , and in particular, in the treatment of apneic episodes in premature infants. 8 Methylxanthines are given to preterm infants both acutely (loading dose) or chronically. 7 The long-term drug-induced blockade of adenosine receptors at early stages of maturation might modify brain development. The outcome of such blockade cannot be predicted from clinical data therefore experimental studies are necessary. In experimental animals, chronic exposure to caffeine during peri-and postnatal period has been shown to result in adaptive long-lasting neurochemical and behavioral responses that are usually opposite to acute drug effects under normal as well as pathological conditions. [9] [10] [11] [12] [13] Only few reports considered the consequences of repeated treatment with this methylxanthine on seizure susceptibility. 11, 14 Similar to the data from adult rodents, repeated caffeine treatment during postnatal period results in a decreased seizure susceptibility in different models of convulsive seizures. Moreover, caffeine effects may delay the decrease in the seizure threshold that occurs for many agents since the late juvenile age. 11, 14 The observed attenuation in the seizure susceptibility after repeated administration of caffeine at low doses of 15-20 mg/kg for 5 days both during adulthood and developmental period correlates with an increase in adenosine A 1 receptor density in specific brain structures. 10, 15 Present experiments represent continuation of our recent findings that repeated caffeine administration at postnatal days 7-11 caused both transient and durable age-specific changes in behaviour and seizure susceptibility. [16] [17] [18] Furthermore, repeated postnatal caffeine administration attenuated sensitivity to convulsant drugs with different mechanisms of action (aminophylline, pentylenetetrazol (PTZ), picrotoxin, bicuculline) in an age-dependent manner. 18 These data suggest that repeated postnatal caffeine administration affects not only adenosinergic system but at least also (probably indirectly) GABAergic inhibitory system.
The aim of the present study was to further specify effects of repeated postnatal caffeine treatment in immature rats on seizures in later life. We hypothesized that effects will depend on the type of elicited seizures. Two models of human seizures with different pathophysiological mechanisms were used -a model of generalized absence seizures with an important role of inhibitory mechanisms and a model of myoclonic seizures with marked convulsions (for review 19 ). Such two models can be elicited by different doses of pentylenetetrazol (PTZ); both are characterized by EEG spike-andwave (SW) rhythm but markedly differ in their behavioral correlates. An acute model of absence seizures can be induced by low doses of PTZ. This model is accepted as a valid model of this type of primary generalized human absence seizures. 20 It is characterized only by EEG spike-and-wave rhythm (rhythmic metrazol activity, RMA) but also by the same motor pattern (behavioral arrest and minimal motor phenomena 21 ) and pharmacological sensitivity 22 as other experimental models of absences such as feline generalized penicillin epilepsy, 23 gamma-hydroxybutyrate-induced model 24 and genetically determined absence seizure GAERS and WAG/Rij rats. 25, 26 Higher doses of PTZ elicit in rodents clonic seizures usually restricted to head and forelimb muscles without a loss of righting reflexes (minimal metrazol seizures of the older literature); tonic component if present consists mainly of torsion of the trunk. 27 These seizures are also characterized by a spike-wave rhythm in the EEG what is in agreement with the clinical data that this rhythm accompanies not only absences but also other types of seizures in epileptic patients. 28 Motor pattern and pharmacological sensitivity suggest that these seizures could be considered as an experimental model of myoclonic seizures. 29 2. Methods
Animals
The experiments were carried out on immature Wistar rats (breeding of the Institute of Physiology, Academy of Sciences, Prague, Czech Republic). Litters consisted from 10 pups; postnatal day 0 was a day of birth. The rats were housed together with their mothers in a temperature-controlled environment (22 AE 1 8C and humidity 50-60%) with a 12/12 h light/dark cycle (lights on at 6 a.m.). Food and water were provided ad libitum (with the exception of the test period). Rat pups were taken from their mothers just before testing. All experiments were approved by the Animal Care and Use Committee of the Institute of Physiology to be in agreement with Animal Protection Law of the Czech Republic (fully compatible with European Community Council directives 86/609/EEC).
Caffeine treatment
Rat pups in each litter were randomly assigned to one control and two experimental groups. Each group consisted of at least 10 animals and contained pups from four or five litters. Caffeine administration started at P7; animals assigned to the experimental groups were injected subcutaneously with either 10 or 20-mg/kg caffeine (Sigma, St. Louis, MO, #C 0750) in a volume of 1-ml/kg body weight. Control rats received saline (1 ml/kg). Injections were repeated daily for 5 days.
Surgery
Four cortical recording electrodes were implanted epidurally over sensorimotor and occipital areas symmetrically over both hemispheres to 18-or 25-day-old rats. Surgical preparation was performed under ether anesthesia. The coordinates were recalculated from the adult brain (AP = 0; L = 2 mm and AP = 6, L = 4 mm, respectively) based on bregma-lambda distance. A reference electrode was placed into the nasal bone and the ground electrode into the occipital bone. All electrodes were fixed to the skull by fast-curing dental acrylic. The surgery lasted less than 10 min. Rats were then placed into plexiglas cages over an electrical heating pad (34 8C, i.e. the temperature in the nest). The animals were allowed to recover for at least 1 h. After the recovery period, righting and placing reflexes were examined and the animals were offered 5% sucrose solution not only as a nutrient but also to check the suckling reflex. Only then the experiment started.
Recording
EEG was registered in a monitoring system (Kaminskij Biomedical Research Systems, Prague); the rate of digitalization was 200 Hz. All rats were allowed to habituate to the environment for 15 min. Control EEG was registered for 10 min, then PTZ was injected and registration continued for at least 30 min, all behavioral phenomena were coded directly into EEG recording.
Experiment 1: rhythmic metrazol activity (RMA) induced with the 20-mg/kg dose of PTZ
Pentetrazol (PTZ; free base) (Sigma, St. Louis, Mo., USA) was freshly dissolved in 0.9 % NaCl solution and administered in a dose of 20 mg/kg (in a volume of 1 ml/kg) intraperitoeneally. Latency to the appearance of the first RMA episode and of the first generalized RMA (GRMA) (i.e. recorded in all four cortical areas) was measured. All RMA episodes (their number and duration) between 10-15 min and 20-25 min after PTZ injection were counted and both total and mean duration of episodes were calculated.
Experiment 2: rhythmic metrazol activity induced with the 40-mg/kg dose of PTZ
Experimental design was the same as in Experiment 1, only the dose of PTZ was 40 mg/kg i.p. Latency to the appearance of the first and the first generalized RMA episode, number and duration of these episodes were counted in the same two 5-min periods as in the first experiment and total and mean duration of episodes were calculated.
Experiment 3: seizures induced with successive doses of PTZ (20 + 40 mg/kg)
Experimental design was again the same as in the first and second experiments, the first 20-mg/kg dose of PTZ was followed after 20 min by the second injection (40 mg/kg). Continuous EEG registration was stopped 30 min after the second dose of PTZ. Presence of RMA episodes after the first dose served as an indicator of PTZ action. Attention was focused on incidence of seizures, their motor pattern and duration.
Statistical analysis
Means and S.E.M. were calculated for all RMA episodes data. The data were subjected to analysis by two-way ANOVA, with factors age (P18 and P25) and drug (saline, caffeine 10 mg/kg, caffeine 20 mg/kg). For all analyses, significant main effects of factors were followed by post hoc analysis using Tukey's test. The incidence of seizures in Experiment 3 was evaluated by Fisher exact test (SigmaStat 1 SPSS). The level of statistical significance was set at 5%.
Results

Experiment 1: rhythmic metrazol activity induced by the 20-mg/kg dose of PTZ
The 20-mg/kg dose of PTZ induced episodes of spike-and-wave activity with a frequency of 4-5 Hz (RMA, Fig. 1 ) accompanied by behavioral arrest in both age groups. This spike-wave rhythm predominated in frontal over occipital regions. Two-way ANOVA showed only a main effect of Age factor on the latency for the appearance of the first RMA [F1,55 = 18.70, p < 0.001], but neither the overall drug nor the age Â drug interaction was significant. The difference between the latencies to the first SW and the first generalized SW episode was not significant (Fig. 2A) . Twenty-fiveday-old rats exhibited shorter latencies for appearance of RMA episodes than 18-day-old ones (Tukey's test: *p < 0.01).
Analysis of variance demonstrated a main effect of drug on the number of RMA episodes in the first (10-15 min) interval after PTZ injection, [F2,56 = 11.70, p < 0.027]. Subsequent pairwise comparisons confirmed that RMA episodes in 18-day-old rats were less frequent in the group treated with the higher dose of 20 mg/kg caffeine at P7-P11 than in control animals (p < 0.03) (Fig. 2B) . In the 20-25 min period after PTZ injection, similar difference was found but the level of significance was reached only in rats treated with lower dose of caffeine (p < 0.005) (Fig. 2B) .
Shorter mean and total duration of RMA episodes were demonstrated in the first interval in the 10-mg/kg caffeine group in comparison with control 18-day-old rats (p < 0.05) (Fig. 2C,D) . Data for the 20-mg/kg group are missing because of a nearly complete absence of the episodes. The interaction Age x Drug and the main effect of age factor were evident for the mean and the total duration of episodes [F2,48 = 20.56, p < 0.0019 and F2,48 = 9.10, p < 0.02, respectively] 20-25 min after PTZ injection. Post hoc comparisons showed that the duration (both mean and total) of episodes was significantly decreased in the two caffeinetreated groups at P18 (Fig. 2 C, D) .
No significant differences were found between control and caffeine-treated groups at the age of 25 days.
3.2. Experiment 2: rhythmic metrazol activity induced by the 40-mg/kg dose of PTZ PTZ given in a dose of 40 mg/kg elicited a marked RMA in all control rats in both age groups. This activity was again formed by SW rhythm with a frequency of about 4-5 Hz. There was no marked difference between 18-and 25-day-old rats in the EEG pattern. Electroclinical correlation was evident with locomotor arrest and/or jerks of vibrissae or other facial muscles accompanying RMA episodes.
As in Experiment 1, 25-day-old control rats showed shorter latencies for appearance of RMA episodes than 18-day-old controls. The difference between the latencies to the first RMA and the first generalized RMA episode was negligible in either age group (Fig. 3A) . Two-way ANOVA revealed a main effect of drug on the latency of the first episode of RMA, [F2,51 = 15.85, p < 0.0035], and a significant age Â drug interaction on both the latency of the first episode of RMA and of the first episode of generalized RMA [F2,51 = 18.64, p < 0.015; F2,51 = 13.03; p < 0.01, respectively]. Tukey's test confirmed that 18-day-old rats in either caffeine group showed shorter latencies than controls for both the first and the first generalized episodes of RMA (*p < 0.05) (Fig. 3A) .
Although ANOVA demonstrated a main effect of drug factor on the number of RMA episodes only in the second period after PTZ injection, [F2,51 = 11.27, p < 0.04], post-hoc test revealed that caffeine-treated groups did not significantly differ from controls (Fig. 3B) . The 20-mg/kg group of 18-day-old rats showed a significant decrease in the incidence of RMA episodes (20% of animals vs. 80% of control rats).
Age factor had an overall effect on the number and the duration (mean and total) of RMA episodes in the first (10) (11) (12) (13) (14) (15) were evident. Subsequent pairwise comparisons confirmed that both mean and total duration of RMA episodes was significantly prolonged in the first period (10-15 min) after PTZ injection in both caffeine groups at P18 (Fig. 3C and D) . Mean but not total duration of RMA episodes was significantly increased in the second period after PTZ injection in 18-day-old rats treated with the lower dose of caffeine. Because of insufficient number of 18-day-old animals with RMA episodes 20-25 min after PTZ in the higher caffeine dose group, data are missing. There were no significant changes of these parameters in 25-day-old rats ( Fig. 3C  and D) .
Experiment 3: motor seizures after two subsequent doses of PTZ
There were no significant changes in the incidence and latency of RMA episodes after the first, 20-mg/kg dose of PTZ when compared with data from Experiment 1.
EEG pattern of minimal seizures after the second dose of PTZ (40 mg/kg) was represented by spike-wave activity with a frequency of about 3 Hz. Motor pattern of seizures was formed by clonic seizures of forelimb and head muscles, tonic component when present was represented by a dorsiflexion of the head or torsion of head and body. Caffeine-treated rats did not exhibit any changes in the EEG and/or motor pattern of seizures. Incidence of minimal clonic seizures were not significantly changed. They were observed in 57%, 88% and 63% of rats in the control, 10-and 20-mg/ kg caffeine 18-day-old groups, respectively. Twenty-five-day old rats exhibited these seizures in 29, 50 and 70% of animals in the control, 10-and 20-mg/kg caffeine groups, respectively (Table 1) . Unexpectedly, generalized tonic-clonic seizures appeared, especially in 43% of control rats in both age groups. The incidence of these seizures tended to increase to 75 in the 10-mg/kg caffeine group of 18-day-old animals (Table 1) . Again, this tendency was not significant. Only control 25-day-old rats exhibited generalized tonic-clonic seizures (three out of seven animals, i.e. 43%), whereas this type of seizures was never observed in either caffeine group. Due to a low incidence of these seizures in control animals, complete suppression did not reach the level of significance.
Discussion
Our present results demonstrated marked difference in the effect of repeated postnatal caffeine treatment on the two models of epileptic seizures characterized by spike-and-wave rhythm in the EEG (rhythmic metrazol activity and minimal clonic seizures). Nonconvulsive seizures, a model of human absence seizures, induced by low doses of PTZ were markedly influenced by early life caffeine exposure. In contrast, convulsive model of human myoclonic seizures was not significantly affected as the incidence, motor and EEG patterns are concerned. This is the first demonstration of the influence of postnatal caffeine treatment on a model of absence seizures. Ordinates: A -latency in seconds, B -number of episodes and C and D -duration in seconds. Asterisks mark significant differences between caffeine groups and controls (ANOVA with subsequent pairwise comparisons using Tukey's test).
Table 1
Effects of chronic treatment with caffeine (10 and 20 mg/kg, s.c.) during P7-P11 on the incidence of clonic and generalized tonic-clonic (GTCS) seizures after 20 + 40 mg/kg PTZ at P18 and P25. Asterisks denote significant difference between control and caffeine groups (Fisher exact test). Analysis of SW rhythm demonstrated thalamocortical mechanism of its generation 33 with a marked role of thalamic reticular nucleus 34 and GABAergic inhibition. 35, 36 Under control conditions, SW EEG rhythm cannot be induced before the third postnatal week in rats 20,32,37 therefore 18-and 25-day-old animals were studied.
Our present results confirmed that the only difference in EEG patterns between the two studied models is in the frequency of EEG rhythmic activity. 38 On the other hand, behaviorally these seizures are completely different: minute jerks of vibrissae accompany RMA episodes induced by low doses of PTZ, whereas minimal clonic seizures present marked convulsions usually restricted to head and forelimb muscles. These motor patterns indicate different spread of epileptic activity into the motor system -to the nuclei of cranial nerves in a model of absences and to the generator of minimal seizures localized in basal forebrain. 39, 40 These two models differ substantially in pharmacological sensitivity. They are differently affected by ethosuximide and to GABA-B receptor agonist baclofen, especially in 18-day-old rats. 38, 41 The third type of epileptic activity recorded in our study, generalized tonic-clonic seizures generated in the brainstem and accompanied by a different EEG pattern (rhythmic spikes transformed into spike-and-wave activity around the transition from the tonic to clonic phase), was not expected under our experimental conditions. They appeared in spite of the fractionated administration of PTZ used to avoid elicitation of this type of seizures. The interval between the two PTZ injections was probably too short to prevent accumulation of the convulsant drug to a suprathreshold level in the brain. There is strong evidence that the effects of caffeine at the low concentrations are due to the antagonism of endogenous adenosine actions. 10 Moreover, it could be speculated that either multiple systems are directly influenced or adenosinergic system could modulate activity of other systems. Although most studies support the hypothesis that antagonism of adenosine receptors is responsible for convulsant action of methylxanthines, Chakrabarti 42 suggested that other mechanisms might also be involved.
Methylxanthines are considered to be weak ligands for benzodiazepine site in vitro, in vivo studies suggest that they affect channel function of the GABA A receptor-channel complex. 9 In spite of the fact that the affinities of caffeine and theophylline for diazepam- binding sites associated with the GABA A receptor channel are very low and might play a role in the convulsant action of high doses of caffeine and theophylline, 43 it cannot be excluded that postnatal caffeine treatment may cause early adaptive changes affecting also GABA A receptor supramolecular complex. Our previous data on changes in susceptibility to convulsants acting on this inhibitory system 18 speak in favour of this possibility.
Early life caffeine treatment resulted in changes in the model of nonconvulsive (absence) seizures in 18-day-old rats but it did not influence this model in 25-day-old rats, i.e. this effect is only transient. This effect changed qualitatively with the intensity of epileptogenic stimulus (dose of PTZ). Anticonvulsant effect was seen if low dose of PTZ was administered whereas the action of the higher dose of PTZ (40 mg/kg) was potentiated. Reduced effects of the 20-mg/kg dose of PTZ (lower number of RMA episodes and their shorter duration) are in agreement with the action of the higher caffeine dose on cortical epileptic afterdischarges. 17 Surprisingly, we found a proconvulsant effect of postnatal caffeine exposure in RMA induced by 40 mg/kg PTZ. Because caffeine and other methylxanthines antagonize both adenosine A 1 and A 2 receptor subtypes with nearly equal affinities (with K i values of 29 and 48 mM, respectively) it is reasonable to assume that these receptor subtypes mediate equally caffeine effects. Adenosine A 2A receptors are present in the forebrain during the postnatal period 15 and caffeine could modify the seizure threshold by its action on this receptor subtype. The results from adult rat hippocampus showed an interaction between co-expressed and co-localized A 2A and A 1 receptors, providing a mixture of excitatory and inhibitory modulation of neuronal excitability. 44 Therefore, the observed increase in seizure susceptibility in caffeine-treated groups at P18 showed in RMA induced by 40 mg/kg PTZ might reflect disturbed balance between inhibitory A 1 and excitatory A 2A receptors in brain areas associated with these seizure phenomena. The controversy between effects on RMA episodes induced by two different doses of PTZ might be due to a change of the dose-effect relationship. Our results suggest that this curve might be shifted to the right but its slope may be steeper than in control animals but further analysis is needed. A failure of significant effects of early life caffeine treatment in our second model -clonic seizures accompanied also by spikewave rhythm -indicates participation of different mechanisms or different brain structures in the effects on models of different types of seizures. In contrast to lack of effect on minimal clonic seizures elicited by PTZ, our previous experiments demonstrated that the 10-mg/kg dose of caffeine administered from P7 to P11 resulted in a proconvulsant effect in cortical epileptic afterdischarges induced by cortical electrical stimulation. 17 Both minimal clonic (metrazol) seizures and cortical epileptic afterdischarges exhibit identical motor pattern and are considered as an analogue of human myoclonic seizures. 29, 30 It indicates that not only motor pattern of convulsions but also the way how these seizures are triggered plays a role in the consequences of early life caffeine treatment. Transition to generalized tonic-clonic seizures in the two control groups and their failure in both caffeine groups of 25-dayold rats was unexpected. Absence of these seizures in caffeinetreated 25-day-old animals might be due to earlier maturation of adenosine receptors in the brainstem than in more rostral parts of the brain. Therefore, they may be influenced by caffeine exposure during early postnatal development in a different way than not yet fully mature adenosine receptors in the forebrain. It remains to be studied if this is a permanent change, i.e. if this effect will appear also in adult animals. Data for cortical epileptic afterdischarges 17 speak in favour of a transient effect.
To conclude, our study demonstrated mixed anti-and proconvulsant effects of early postnatal caffeine exposure in a model of human absence seizures. These effects were age-and dose-dependent. An outlined anticonvulsant effect on generalized tonic-clonic seizures is in accordance with previous reports demonstrating anticonvulsant consequences of early life caffeine exposure in majority of seizure models. 11, 14, 18 
